Ness Ziona, Israel

Tsvee Lapidot


 

Average Co-Inventor Count = 2.7

ph-index = 5

Forward Citations = 69(Granted Patents)


Location History:

  • Ness-Ziona, IL (2007 - 2015)
  • Nes-Ziona, IL (2006 - 2017)

Company Filing History:


Years Active: 2006-2017

Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: Tsvee Lapidot: Innovator in Hematopoietic Cell Modulation

Introduction

Tsvee Lapidot is a prominent inventor based in Ness Ziona, Israel. He has made significant contributions to the field of hematopoietic cell research, holding a total of 9 patents. His work focuses on developing innovative peptides that have the potential to transform cancer treatment and stem cell therapy.

Latest Patents

One of his latest inventions involves short beta-defensin-derived peptides. This invention is directed to β-defensin-derived peptides and their use in modulating the activity of hematopoietic cells, particularly hematopoietic stem cells and progenitor cells. The invention provides compositions and methods useful for promoting the mobilization and transplantation of these cells. Additionally, it offers compositions and methods that are beneficial in the treatment of cancer. Another patent also centers on short beta-defensin-derived peptides, emphasizing their role in modulating the activity of hematopoietic cells and other CXCR4-expressing cells, further contributing to cancer treatment and stem cell mobilization.

Career Highlights

Tsvee Lapidot is associated with Yeda Research and Development Co. Ltd., where he continues to advance his research and innovations. His work has garnered attention in the scientific community for its potential applications in medicine.

Collaborations

He collaborates with notable colleagues, including Orit Kollet and Alexander Kalinkovich, who contribute to his research endeavors.

Conclusion

Tsvee Lapidot's innovative work in hematopoietic cell modulation showcases his commitment to advancing medical science. His patents reflect a dedication to improving cancer treatment and stem cell therapies, making him a significant figure in his field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…